The purpose of this clinical trial is to trial is to learn more about a new, investigational, once daily medication, called baxdrostat, and its ability to lower blood pressure in individuals not responding to their current treatment.

Eligible patients include those who currently have a diagnosis of high blood pressure, despite currently taking anti-hypertensive medications.